查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138381

2022-2029 年全球結核病檢測市場

Global Tuberculosis Testing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

結核病檢測市場受到結核病和耐多藥結核病負擔增加、政府舉措增加以及新興市場意識提高的推動。

預計日益增加的結核病負擔將推動市場增長。

感染冠狀病毒的人數和肺結核患者人數的增加將推動市場。據世界衛生組織 (WHO) 估計，2020 年全球將有 1000 萬人死於結核病，其中包括 560 萬男性、330 萬女性和 110 萬兒童，佔全球結核病死亡人數的一半。推動市場增長的因素包括結核病和耐多藥結核病負擔的增加、研發投資的增加、產品線的擴大以及新興市場的政府舉措增加。在過去十年中，結核病診斷領域發生了巨大變化。此外，為了響應世衛組織的全球結核病規劃，它實施了一個系統和動態的過程，用於評估技術和製定政策以推動市場增長。

此外，結核病的患病率逐年增加，預計將在預測期內推動市場以及影響人們選擇診斷測試（例如 X 射線檢查）的政府宣傳計劃的數量。隨著市場上存在促進基礎結核病研究和加速管道診斷市場批准的機會，預計市場也將增長。此外，診斷提供商可以利用基因組學和蛋白□□質組學的技術發展來促進結核病診斷產品的開發。

提高高負擔地區的篩查率、降低診斷試劑的成本、先進的研究方法、快速的臨床決策和降低死亡率是發展的重點。這些努力的結果是預防/治療診斷率的提高。因此，對診斷測試的需求增加，結核病診斷藥物市場被激活。此外，政府和獨立醫療機構正在努力遏制這種傳染病的傳播。提高對診斷重要性的認識對於提高篩查和診斷率至關重要，有助於進一步繁榮結核病診斷市場。這些因素正在推動預測期內的市場增長。例如，印度修訂的國家結核病控制計劃 (RNTCP) 側重於通過免費診斷和治療計劃進行結核病篩查和改善獲得治療的機會。該計劃的公私合作夥伴關係也提高了診斷率。

60 歲及以上的人群是結核病診斷市場的目標人群，因為他們更容易感染傳染病。因此，不斷增長的老年人口正在推動市場的增長。

結核病藥物引起的耐藥性預計將阻礙市場增長。

然而，結核病耐藥性是醫護人員最關心的問題之一。由於錯誤的藥物方案和不適當的劑型導致治療不充分，導致接受治療的肺結核患者產生耐藥性，抑制了市場增長。

行業分析

全球結核病檢測市場根據波特五力、監管分析、供應鏈分析、定價分析、產品創新和未滿足的需求等各種行業因素對市場進行了深入分析。

全球結核病檢測市場報告包含大約 45 多個市場數據表、40 多個數字和 180 頁。

內容

第 1 章全球結核病檢測市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章全球結核病檢測市場 - 市場定義和概述

第 3 章全球結核病檢測市場 - 執行摘要

  • 按測試類型劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章全球結核病檢測市場動態

  • 市場影響因素
    • 驅動程序
      • 結核病和耐多藥結核病的負擔日益加重
      • 新興市場的政府努力和日益增強的意識
    • 限制因素
      • 肺結核診斷費用高
      • 抗結核藥物
  • 影響分析
  • 機會

第 5 章全球結核病檢測市場 - 行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 產品分析
  • 工業價值鏈分析

第 6 章全球結核病檢測市場 - 按檢測類型

  • 核酸肌鬆
  • 細胞因子檢測法
  • 檢測潛伏感染
  • 培養肌樣試驗
  • 藥物敏感肌生長抑制素
  • 其他

第 7 章。全球結核病檢測市場 - 按最終用戶分類

  • 醫院檢查室
  • 研究所
  • 診所檢查室
  • 診斷中心

第 8 章。全球結核病檢測市場 - 按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章。全球結核病檢測市場的競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 10 章全球結核病檢測市場公司簡介

  • Thermo Fisher Scientific, Inc.
    • 公司概況
    • 產品組合和描述
    • 主要發展狀況
    • 財務摘要
  • Hologic Corporation
  • Abbott Laboratories
  • Alere, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • bioMerieux SA
  • Sanofi.
  • Cepheid
  • List is not exhaustive

第 11 章全球結核病檢測市場 - 主要考慮因素

第 12 章全球結核病檢測市場數據M

簡介目錄
Product Code: DMMD2595

Market Overview

The Tuberculosis Testing Market size was valued at US$ 1,337.10 million in 2021 and is estimated to reach US$ 2058.0 million by 2029, growing at a CAGR of 6.0% during the forecast period (2022-2029).

Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent. It is caused by the bacillus Mycobacterium tuberculosis, which is spread when sick people with TB expel bacteria into the air, for example, by coughing. It typically affects the lungs (pulmonary TB) but can also affect other sites. About a quarter of the world's population is infected with M. tuberculosis and thus at risk of developing TB disease. Tuberculosis testing can be defined as the most commonly used diagnostic tool for tuberculosis. With a timely diagnosis and treatment with first-line antibiotics for 6 months, most people who develop TB can be cured, and onward transmission of infection curtailed. The number of TB cases occurring each year can also be driven down by reducing the prevalence of health-related risk factors for TB providing preventive treatment to people.

Market Dynamics

The tuberculosis testing market is driven by the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing government initiatives and rising awareness in the emerging market.

Increasing burden of tuberculosis are expected to drive market growth.

The market is driven by the increasing number of coronavirus cases, increasing the number of tuberculosis patients. According to the World Health Organization (WHO), in 2020, an estimated 10 million people fell ill with tuberculosis (TB) worldwide, 5.6 million men, 3.3 million women and 1.1 million children, which is more than half of global TB deaths. Factors propelling the market's growth include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets. The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to the WHO Global TB program, it has implemented a systematic and dynamic process used to evaluate technologies and develop policies, which has enhanced the market's growth.

The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that influence people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period. The market is also expected to witness growth as there is an opportunity for players in the market to accelerate their pipeline diagnostic products' market approval by spurring the fundamental research in TB. Additionally, technological developments in genomics and proteomics can be leveraged by diagnostic providers to hasten product development in TB diagnostics.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the results of these initiatives. This has led to a subsequent upsurge in demand for diagnostic tests and the TB diagnostics market. Furthermore, the government and independent healthcare organizations have undertaken initiatives to control this infectious disease's proliferation. Creating awareness about the importance of diagnosis is vital in increasing the screening and diagnosis rates, further helping the TB diagnostics market flourish. This factor is driving the growth of the market in the forecast period. For instance, the Revised National Tuberculosis Control Program (RNTCP) in India focuses on performing TB screening and providing greater access to treatment through free diagnosis & treatment programs. Besides, private-public partnerships under this program are boosting the diagnosis rate.

Population above the age of 60 is the target population for the TB diagnostics market as this demographic is susceptible to infectious diseases. The growing geriatric population base, as a result, is driving the growth of the market.

Drug resistance with tuberculosis drugs is expected to hamper the market growth.

However, drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimens and incorrect dosage forms lead to drug resistance in TB patients undergoing treatment, restraining the market's growth.

Industry Analysis

The global tuberculosis testing market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, Unmet Needs.

Segment Analysis

Test type segment is expected to hold the largest market share in global Tuberculosis Testing market

The global tuberculosis testing market is segmented on test type by Cytokine Detection Assay, Nuclеic Acid Tеsting, Detection of Latent Infection, Culturе Basеd Tеsts, Drug Suscеptibility Tеsting, and Othеrs. The Nuclеic Acid Tеsting segment held the largest market share due to its use as diagnostic tools for tuberculosis (TB) for many years, and which continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, these tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests and even provide greater speed than culture-based tests. A nucleic acid test for tuberculosis (TB) is a molecular test used to detect the DNA (deoxyribonucleic acid) of Mycobacterium tuberculosis complex (MTBC) in sputum or other respiratory samples. Because the amount of DNA in a sample is minimal, NAA testing includes a step that amplifies (or copies) the genetic material. Polymerase Chain Reaction (PCR) is a common form of nucleic acid test used in laboratory diagnosis. Drug Suscеptibility Tеsting is expected to have positive market growth because they are cost-efficient and easy-to-perform. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies, thus contributing to its growth.

A Cytokine Detection Assay is usually employed to check for the specific cytokines being secreted. This is more a function of biochemistry research rather than a specific test for body functions. Cytokines and their receptors are under a great deal of research because of their role in disease control. It is worth noting that many cytokines have an opposing and sometimes complementary effect on each other; thereby, modulating the immune response's severity. Cytokine assays are used to identify which cytokines and their deficiencies are responsible for the cause of some autoimmune diseases.

A Detection of Latent Infection The goal of testing for LTBI is to identify individuals at increased risk for developing tuberculosis (TB) and, therefore, who would benefit from treatment of latent TB infection. Only those who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive. This factor would drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global tuberculosis testing market

By region, the Tuberculosis Testing market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Asia-Pacific dominated the global tuberculosis testing market and is expected to grow at the highest CAGR during the forecast period. The growth of the market in the region is attributed to tuberculosis's high burden and the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the TB diagnostics market's growth. The high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease. Besides, in countries such as India, according to the recent budget announcement, the Government of India aims to eliminate tuberculosis by 2025, which is expected to act as one of the major factors for the growth of the Asia-Pacific market forecast period.

Infectious and Endemic Disease Control in China, RNTCP in India, and the National TB program in Afghanistan are the few programs planned by local healthcare agencies to contain the incidence and ensure equitable access to diagnosis. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for controlling this communicable disease.

Competitive Landscape

The global tuberculosis testing market is highly competitive, with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, are the leading market players with significant market share.

Key Companies to Watch

Abbott Laboratories:

Overview: Abbott is American multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products and branded generic medicines.

Product Portfolio:

The Abbott RealTime MTB assay is an in vitro polymerase chain reaction (PCR) assay for the qualitative detection of MTB complex DNA in smear positive or smear negative specimen of sputum or bronchial alveolar lavage and N-acetyl-L-cysteine (NALC)-prepared sediments prepared from sputum and broncial alveolar lavage collected from individuals suspected of having tuberculosis (TB).

The global tuberculosis testing market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Global Tuberculosis Testing Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Tuberculosis Testing Market - Market Definition and Overview

3. Global Tuberculosis Testing Market- Executive Summary

  • 3.1. Market Snippet by Test Type
  • 3.2. Market Snippet by End User
  • 3.3. Market Snippet by Region

4. Global Tuberculosis Testing Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing burden of tuberculosis and multidrug-resistant Tuberculosis
      • 4.1.1.2. Increasing government initiatives and rising awareness in the emerging Market
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with tuberculosis diagnostics
      • 4.1.2.2. Resistance to the TB medicines
  • 4.2. Impact Analysis
  • 4.3. Opportunity

5. Global Tuberculosis Testing Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Analysis
  • 5.6. Industry Value Chain Analysis

6. Global Tuberculosis Testing Market - By Test Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 6.3. Market Attractiveness Index, By Test Type
    • 6.3.1. Nuclеic Acid Tеsting*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 6.3.2. Cytokine Detection Assay
    • 6.3.3. Detection of Latent Infection
    • 6.3.4. Culturе Basеd Tеsts
    • 6.3.5. Drug Suscеptibility Tеsting
    • 6.3.6. Others

7. Global Tuberculosis Testing Market - By End-User

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 7.3. Market Attractiveness Index, By End User
    • 7.3.1. Hospital laboratories*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, USD Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2027
    • 7.3.2. Research laboratories
    • 7.3.3. Clinics laboratories
    • 7.3.4. Diagnostic center

8. Global Tuberculosis Testing Market - By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America*
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. U.S.
      • 8.4.5.2. Canada
      • 8.4.5.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. Germany
      • 8.5.5.2. U.K.
      • 8.5.5.3. France
      • 8.5.5.4. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.5.1. Brazil
      • 8.6.5.2. Argentina
      • 8.6.5.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.5.1. China
      • 8.7.5.2. India
      • 8.7.5.3. Japan
      • 8.7.5.4. Australia
      • 8.7.5.5. Rest of Asia Pacific
  • 8.8. The Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9. Global Tuberculosis Testing Market Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Global Tuberculosis Testing Market Company Profiles

  • 10.1. Thermo Fisher Scientific, Inc. *
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Developments
    • 10.1.4. Financial Overview
  • 10.2. Hologic Corporation
  • 10.3. Abbott Laboratories
  • 10.4. Alere, Inc.
  • 10.5. Lupin Pharmaceuticals, Inc.
  • 10.6. Becton, Dickinson and Company
  • 10.7. F. Hoffmann-La Roche AG
  • 10.8. bioMerieux SA
  • 10.9. Sanofi.
  • 10.10. Cepheid
  • List is not exhaustive

11. Global Tuberculosis Testing Market - Premium Insights

12. Global Tuberculosis Testing Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us